awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33442949-94F25869-532C-4C91-8A95-A38CF8AD11BD
Q33442949-94F25869-532C-4C91-8A95-A38CF8AD11BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442949-94F25869-532C-4C91-8A95-A38CF8AD11BD
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.
P2860
Q33442949-94F25869-532C-4C91-8A95-A38CF8AD11BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442949-94F25869-532C-4C91-8A95-A38CF8AD11BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbb2cac0291b3417f1f2e4b0a46ee7146fe8d948
P2860
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation